Cargando…

Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience

Hepatocellular carcinoma (HCC) is a challenging to treat malignancy with few available systemic therapies. Angiogenesis has been implicated in the pathogenesis of HCC and prior studies have suggested a role for anti‐VEGF therapy. Prior to FDA approval of second‐line therapy for advanced HCC, from 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wattenberg, Max M., Damjanov, Nevena, Kaplan, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488135/ https://www.ncbi.nlm.nih.gov/pubmed/30790466 http://dx.doi.org/10.1002/cam4.2015

Ejemplares similares

The impact of primary tumor sidedness on survival in early‐onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis
por: Azar, Ibrahim, et al.
Publicado: (2021)

Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration
por: Aspinall, Sherrie L., et al.
Publicado: (2019)

Outcomes of Veterans Treated in Veterans Affairs Hospitals vs Non–Veterans Affairs Hospitals
por: Yoon, Jean, et al.
Publicado: (2023)

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2022)

Characterization of response to atezolizumab + bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial
por: Salem, Riad, et al.
Publicado: (2021)

The effect of pre-existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs (VA) medical center
por: Wadia, Roxanne J, et al.
Publicado: (2015)

Women Veterans’ Healthcare Needs, Utilization, and Preferences in Veterans Affairs Primary Care Settings
por: Sheahan, Kate L., et al.
Publicado: (2022)

Choosing Veterans Affairs: Determinants of post-9/11 Veterans’ enrollment in Veterans Affairs health care
por: Vanneman, Megan E., et al.
Publicado: (2023)

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
por: Fessas, Petros, et al.
Publicado: (2020)

Transgender Veterans and the Veterans Health Administration: Exploring the Experiences of Transgender Veterans in the Veterans Affairs Healthcare System
por: Rosentel, Kris, et al.
Publicado: (2016)

A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
por: Uronis, Hope E, et al.
Publicado: (2013)

Therapeutic Hypothermia after Cardiac Arrest: Experience at an Academically Affiliated Community-Based Veterans Affairs Medical Center
por: Shah, Maulik P., et al.
Publicado: (2011)

Comparing Driving Miles for Department of Veterans Affairs–delivered Versus Department of Veterans Affairs–purchased Cataract Surgery
por: Pettey, Warren B.P., et al.
Publicado: (2021)

Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
por: Yin, Xiaoqiang, et al.
Publicado: (2022)

The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
por: Zhu, Jie, et al.
Publicado: (2021)

Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer
por: Laslett, Nicole F., et al.
Publicado: (2018)

Association of Expanded Health Care Networks With Utilization Among Veterans Affairs Enrollees
por: Rose, Liam, et al.
Publicado: (2021)

555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
por: Caffrey, Aisling, et al.
Publicado: (2021)

Evaluation of the Significance of Pretreatment Liver Biopsy and Baseline Mental Health Disorder Diagnosis on Hepatitis C Treatment Completion Rates at a Veterans Affairs Medical Center
por: Kluck, Joseph, et al.
Publicado: (2013)

Vaccinating Veterans for COVID-19 at the U.S. Department of Veterans Affairs
por: Der-Martirosian, Claudia, et al.
Publicado: (2022)

Sleep Apnea Syndrome Represents a Risk for Glaucoma in a Veterans' Affairs Population
por: Boyle-Walker, Megan, et al.
Publicado: (2011)

The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units
por: Vangala, Chandan, et al.
Publicado: (2021)

Association Between Self-Reported Health and Reliance on Veterans Affairs for Health Care Among Veterans Affairs Enrollees
por: Rose, Liam, et al.
Publicado: (2023)

Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
por: Dharmapuri, Sirish, et al.
Publicado: (2020)

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
por: Hsu, C-H, et al.
Publicado: (2010)

Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France
por: Gaugain, Loïg, et al.
Publicado: (2023)

Evaluating User Experiences of the Secure Messaging Tool on the Veterans Affairs’ Patient Portal System
por: Haun, Jolie N, et al.
Publicado: (2014)

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
por: Harding, James J., et al.
Publicado: (2021)

Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial
por: Bazarbashi, Shouki, et al.
Publicado: (2023)

Development and Implementation of Multidisciplinary Liver Tumor Boards in the Veterans Affairs Health Care System: A 10-Year Experience
por: Rabiee, Atoosa, et al.
Publicado: (2021)

The Veterans Choice Act and Technical Efficiency of Veterans Affairs (VA) Hospitals
por: Oh, Dongjin, et al.
Publicado: (2022)

Immunotherapies for hepatocellular carcinoma
por: Liu, Justin K. H., et al.
Publicado: (2021)

Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study
por: Nakano, Masahito, et al.
Publicado: (2015)

Health Care Access Expansions and Use of Veterans Affairs and Other Hospitals by Veterans
por: Yoon, Jean, et al.
Publicado: (2022)

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
por: Friedman, Claire F, et al.
Publicado: (2020)

Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
por: Reig, Maria, et al.
Publicado: (2020)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
por: El Dika, Imane, et al.
Publicado: (2020)

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
por: Lou, Emil, et al.
Publicado: (2013)

Effectiveness of the Tobacco Tactics program in the Department of Veterans Affairs
por: Duffy, Sonia A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gk9m433uk9a0orfn0ma0b82agb